Moderna lifts annual revenue forecast

MODERNA lifted its full-year revenue forecast on Friday after strong international Covid-19 vaccine demand and payments from partnerships helped the biotech swing to profit in the third quarter, sending its shares up over 10 percent.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.